Entering text into the input field will update the search result below

Merck Ebola vaccine OK'd in four African countries

Feb. 14, 2020 11:52 AM ETMerck & Co., Inc. (MRK) StockBy: Douglas W. House, SA News Editor2 Comments
  • Merck (NYSE:MRK +0.3%) announces that Ervebo (Ebola Zaire Vaccine, Live) is now approved in Democratic Republic of Congo, Burundi, Ghana and Zambia for prevention of disease caused by Zaire ebolavirus in people at least 18 years old.

Recommended For You

About MRK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRK--
Merck & Co., Inc.